Caricamento...

New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir

Letermovir is a human cytomegalovirus (CMV) terminase inhibitor recently approved as prophylaxis in stem cell transplant recipients. In further studies of emerging drug resistance, a baseline laboratory CMV strain was serially propagated in cell culture under a combination of letermovir and ganciclo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Chou, Sunwen, Satterwhite, L. Elizabeth, Ercolani, Ronald J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125535/
https://ncbi.nlm.nih.gov/pubmed/29914965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00922-18
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !